Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
Top Cited Papers
- 31 May 2010
- journal article
- review article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 21 (5), 315-324
- https://doi.org/10.1016/j.tem.2010.01.002
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in CancerCell, 2009
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- Regulation of Androgen Receptor Transcriptional Activity and Specificity by RNF6-Induced UbiquitinationCancer Cell, 2009
- Oncogenic activation of androgen receptorUrologic Oncology, 2009
- Mechanisms mediating androgen receptor reactivation after castrationUrologic Oncology: Seminars and Original Investigations, 2009
- Targeting the androgen receptor pathway in prostate cancerCurrent Opinion in Pharmacology, 2008
- Pre-receptor regulation of the androgen receptorMolecular and Cellular Endocrinology, 2008
- An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignanciesBiochemical Pharmacology, 2008
- Human aldo–keto reductases: Function, gene regulation, and single nucleotide polymorphismsArchives of Biochemistry and Biophysics, 2007
- Identification of the molecular switch that regulates access of 5α-DHT to the androgen receptorMolecular and Cellular Endocrinology, 2007